BALLESTRI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 4.358
EU - Europa 1.249
AS - Asia 330
SA - Sud America 9
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 5.959
Nazione #
US - Stati Uniti d'America 4.349
GB - Regno Unito 463
SE - Svezia 224
IT - Italia 156
CN - Cina 152
DE - Germania 151
UA - Ucraina 84
TR - Turchia 67
HK - Hong Kong 56
FI - Finlandia 48
BG - Bulgaria 42
FR - Francia 33
RU - Federazione Russa 16
IN - India 11
VN - Vietnam 11
CA - Canada 9
MY - Malesia 8
BE - Belgio 7
BR - Brasile 7
AU - Australia 5
IE - Irlanda 5
RO - Romania 5
EU - Europa 4
NL - Olanda 4
SG - Singapore 4
JP - Giappone 3
KR - Corea 3
PH - Filippine 3
CH - Svizzera 2
IR - Iran 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SI - Slovenia 2
TJ - Tagikistan 2
TW - Taiwan 2
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
ES - Italia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 5.959
Città #
Fairfield 759
Woodbridge 461
Ashburn 369
Houston 356
Southend 338
Seattle 334
Chandler 312
Wilmington 295
Cambridge 246
Dearborn 192
Ann Arbor 182
Nyköping 165
Jacksonville 135
Modena 80
New York 67
Beijing 56
Hong Kong 56
Eugene 43
Izmir 43
Princeton 43
San Diego 43
Sofia 42
Helsinki 26
London 21
Shanghai 18
Redwood City 17
Des Moines 14
San Mateo 12
Dong Ket 10
Bremen 9
Hefei 9
Brussels 7
Falls Church 7
Nanjing 7
Norwalk 7
Jinan 6
Boardman 5
Dublin 5
Florence 5
Frankfurt am Main 5
Fremont 5
Kunming 5
Phoenix 5
Augusta 4
Chiswick 4
Livorno 4
Molise 4
Ottawa 4
Padova 4
Rome 4
São Paulo 4
Bari 3
Bologna 3
Chicago 3
Cluj-Napoca 3
Guangzhou 3
Hebei 3
Kilburn 3
Leawood 3
Maastricht 3
Monmouth Junction 3
Nanchang 3
San Francisco 3
Toronto 3
Acton 2
Auburn Hills 2
Auckland 2
Barletta 2
Betton 2
Canberra 2
Chennai 2
Cremona 2
Dongguan 2
Faenza 2
Fuzhou 2
Grafing 2
Hangzhou 2
Las Vegas 2
Paris 2
Romainville 2
Salerno 2
Shenyang 2
Tokyo 2
Vigevano 2
Abbiategrasso 1
Amadora 1
Andria 1
Ardabil 1
Baotou 1
Battipaglia 1
Berlin 1
Bolton 1
Brest 1
Budapest 1
Buffalo 1
Castelnuovo Rangone 1
Changsha 1
Chascomus 1
Chennevières-sur-marne 1
Chongqing 1
Totale 4.949
Nome #
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 295
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 230
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 204
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 197
Nonalcoholic fatty liver disease and aging: epidemiology to management 184
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 183
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 181
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 176
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 176
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 174
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 171
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 170
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 169
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 165
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 165
A critical appraisal of the use of ultrasound in hepatic steatosis 164
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 159
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 157
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 149
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 142
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 137
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 135
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 134
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 132
Alcohol and Steatosis: The Japanese Paradox 130
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? 128
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 127
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 124
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 124
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 120
Clinical relevance of liver histopathology and different histological classifications of NASH in adults 114
Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity? 114
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk 114
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps 111
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 109
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 107
Hypervascular Retroperitoneal Mass in a Patient with Fever and Leucocytosis - Contrast-Enhanced Ultrasonographic Findings in a Case of Inflammatory Malignant Fibrous Histiocytoma 97
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? 96
Nanoparticles: potential toxins for the organism and the kidney ? 95
Gli enzimi epatobiliari nella diagnostica clinica delle Epatopatie. 94
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 84
Totale 6.037
Categoria #
all - tutte 23.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019464 0 0 0 0 0 0 0 0 0 70 181 213
2019/20201.711 103 87 94 120 162 279 290 187 174 66 92 57
2020/20211.266 109 67 103 116 123 129 82 161 63 135 114 64
2021/2022782 34 95 77 31 17 37 48 29 102 75 172 65
2022/2023827 82 126 62 76 87 116 16 79 96 8 34 45
2023/2024336 15 25 42 24 97 61 21 39 10 2 0 0
Totale 6.037